Wang L, Muxin G, Nishida H, Shirakawa C, Sato S, Konishi T
Understanding how the microbiome is involved in establishing, maintaining, and reversing obesity has been an active area of research 14,15,16 , and has included studies investigating links between the microbiome and obesity-related comorbidities such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 17,18
A notable example includes the co-delivery of resveratrol and paclitaxel via PEGylated liposomes, which exhibited potent cytotoxicity against drug-resistant breast cancer cells (MCF-7/Adr) in vitro and enhanced tumor retention in vivo without increasing systemic toxicity
Not surprisingly, food and feed also contain the most complex mixture of low-molecular-weight xenobiotics to which humans and animals are exposed
Janoshik COA available per batch on request
Cellular Molecular Medicine 25 (5), 26452654